col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


23 Results       Page 1

 [1] 
Oxford University Press: American Journal of Hypertension
  original article Date Title Authors   All Authors
1 [GO] 2025―May―18 Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in France Clément Mathieu, Julien Bezin, Antoine Pariente
2 [GO] 2025―May―13 Medical Costs, Health Care Utilization, and Productivity Losses Associated with Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees Jun Soo Lee, Yidan (Xue) Zhang, Yu Wang, Joohyun Park, Ashutosh Kumar, Bruce Donald, et al. (+2)
3 [GO] 2025―Apr―18 A Transformer-Based Framework for Counterfactual Estimation of Antihypertensive Treatment Effect on COVID-19 Infection Risk - A Proof-of-Concept Study Tran Q B Tran, Stefanie Lip, Honghan Wu, Shyam Visweswaran, Jill P Pell, Sandosh Padmanabhan
4 [GO] 2025―Jan―31 Effect of COVID-19 Pandemic Related Healthcare Disruption on Hypertension Control: A Retrospective Analysis of Older Adults With Multiple Chronic Conditions in New York City Darcy Banco, Rania Kanchi, Jasmin Divers, Samrachana Adhikari, Andrea Titus, Nichola Davis, et al. (+5)
5 [GO] 2024―Mar―12 Changes in self-measured blood pressure monitoring use in 14 states from 2019 to 2021 - Impact of the COVID-19 pandemic Jing Fang, Wen Zhou, Donald K Hayes, Hilary K Wall, Gregory Wozniak, Alina Chung, Fleetwood Loustalot
6 [GO] 2023―Sep―29 Rural and Urban Differences in Hypertension Management Through Telehealth Before and During the COVID-19 Pandemic Among Commercially Insured Patients Jun Soo Lee, Ami Bhatt, Sandra L Jackson, Lisa M Pollack, Nina Omeaku, Kincaid Lowe, et al. (+3)
7 [GO] 2023―May―30 Clinical Practice Changes in Monitoring Hypertension Early in the COVID-19 Pandemic by Robbins et al. Am J Hypertens (2022) 35 (7): 596-600. https://doi.org/10.1093/ajh/hpac049
8 [GO] 2023―Apr―22 Trends and Characteristics of Blood Pressure Prescription Fills Before and During the COVID-19 Pandemic in the United States Peter K Yang, So Youn Park, Sandra L Jackson, Sharon Attipoe-Dorcoo, Elizabeth Gray, Matthew D Ritchey, Laurence S Sperling
9 [GO] 2023―Apr―03 Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic Lweendo Muchaili, Bislom C Mweene, Sepiso K Masenga
10 [GO] 2023―Mar―24 Discontinuation of Renin-Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic Paul Muntner, Kathryn Foti, Zhixin Wang, Chibuike J Alanaeme, Eunhee Choi, Adam P Bress, et al. (+2)
11 [GO] 2022―Aug―24 24-Hour Central Hemodynamic Load in Adults With and Without a History of COVID-19 Andrew R Heckel, Danielle M Arcidiacono, Kailee A Coonan, Alaina C Glasgow, Jacob P DeBlois, Brooks B Gump, et al. (+2)
12 [GO] 2022―Jun―03 An updated systematic review and meta-analysis of randomized trials on the effects of angiotensin II receptor blockers on the risk of mortality in patients with COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
13 [GO] 2022―Apr―11 Clinical Practice Changes in Monitoring Hypertension early in the COVID-19 Pandemic Cheryl L Robbins, Nicole D Ford, Donald K Hayes, Jean Y Ko, Elena Kuklina, Shanna Cox, et al. (+2)
14 [GO] 2021―Aug―16 Updates on renin-angiotensin system blockers in hypertensive patients with COVID-19 Shigeru Shibata, Takuya Kishi
15 [GO] 2021―Jul―14 Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial Farhad Najmeddin, Maedeh Solhjoo, Haleh Ashraf, Mohammadreza Salehi, Fatemeh Rasooli, Morteza Ghoghaei, et al. (+2)
16 [GO] 2021―Jun―22 The Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker on the Outcome of Hospitalization of Patients With Hypertension and COVID-19 Xi-jing Zhuang, Wen-jun Wang, Xiao-hui Zhao, Wei Wei, Wei-wang Fan, Kai Gao, et al. (+2)
17 [GO] 2021―Jun―12 Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19 Victor G O Evangelho, Murilo L Bello, Helena C Castro, Marcia R Amorim
18 [GO] 2020―Dec―31 SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING Pavel Hamet, Zdenka Pausova, Redha Attaoua, Camil Hishmih, Mounsif Haloui, Jean Shin, et al. (+8)
19 [GO] 2020―Nov―03 Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and COVID-19: Demonstrating the Actionability of Real World Evidence Sean Hennessy, Jordana B Cohen
20 [GO] 2020―Nov―03 How important is the assessment of soluble ACE-2 in COVID-19? Manuel Rojas, Yeny Acosta-Ampudia, Diana M. Monsalve, Carolina Ramírez-Santana, Juan-Manuel Anaya
21 [GO] 2020―Sep―11 Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19 Abbas Soleimani, Sina Kazemian, Shahrokh Karbalai Saleh, Arya Aminorroaya, Zahra Shajari, Azar Hadadi, et al. (+9)
22 [GO] 2020―Jun―05 Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives C Felice, C Nardin, G L Di Tanna, U Grossi, E Bernardi, L Scaldaferri, et al. (+12)
23 [GO] 2020―May―21 Cost-Related Antihypertensive Medication Nonadherence:Action in the Time of COVID-19 and Beyond Gabriel S Tajeu, Paul Muntner
 [1] 

23 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec